Search results
Results from the WOW.Com Content Network
GRAIL, Inc. is an American biotechnology company based in Menlo Park, California. It was previously a subsidiary of Illumina started as a startup seeking to develop an early cancer screening test for people who do not have symptoms. [3] Grail was spun-out from Illumina on June 24, 2024.
Grail is working with a blood test trial with over 120,000 women during scheduled mammogram visits in the states of Minnesota and Wisconsin, as well as a partnership with the Mayo Clinic. Grail uses Illumina sequencing technology for tests. [26] Grail planned to roll out the tests by 2019. [27]
The blood test, called Galleri, can detect multiple types of cancer early and targets 80% of cancers currently not screened for that result in cancer deaths, Grail CEO Bob Ragu
Grail, valued at $7.1 billion under Illumina's deal, is seeking to market a blood test that can diagnose many kinds of cancer, known as a liquid biopsy. Illumina had spun off Grail in 2016 but ...
Nearly four years after pitching for Grail, Illumina finally separated the cancer blood test developer.To expand its reach in single-cell analysis and multiomics research, Illumina acquired ...
In 2018 data from Grail's first clinical trial for the Galleri test, the Circulating Cell-free Genome Atlas Study, [5] the test detected 87% of late-stage cancers and 38% of early-stage cancers. [6] The test does not diagnose cancer; [7] rather, it detects possible signs of cancer in order to help direct follow-up diagnostic testing. [8]
As an independent company, Grail is betting on commercial partnerships with health systems, employers and life insurance companies of its flagship cancer-detection test to power its near-term growth.
Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States.Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease.